Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genistein as an add-on treatment for cystic fibrosis
2016-001619-19Phase 2Active
- Sponsor
- University Medical Center Utrecht
- Start
- Mar 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cystic fibrosis (CF) comparing Ivacaftor + genistein with Ivacaftor + placebo (2 arms). Primary endpoint: %FEV1 change with genistein vs placebo. Started Mar 2017; status: active.
02
Drugs
genistein
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on 2016-001619-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001619-19.